Insider Trading & Ownership - Ho Robert

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Ho Robert
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-03-17
Sale
2021-03-18
8:44 pm
Neoleukin Therapeutics Inc.NLTXHo Robert
Chief Financial Officer
6,497$11.01$71,55671,503
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-03-06
Option Award
2023-03-08
4:58 pm
N/A
2032-03-24
Third Harmonic Bio Inc.THRDHo Robert
Chief Financial Officer
598,955$0598,955
(Direct)
View
2023-03-06
Disposition
2023-03-08
4:58 pm
N/A
2032-03-24
Third Harmonic Bio Inc.THRDHo Robert
Chief Financial Officer
462,955$0598,955
(Direct)
View
2022-10-25
Option Award
2022-10-27
4:51 pm
N/A
2032-10-24
Third Harmonic Bio Inc.THRDHo Robert
Chief Financial Officer
95,000$095,000
(Direct)
View

Ownership
2022-09-14
6:11 pm
N/A
2032-03-24
Third Harmonic Bio Inc.THRDHo Robert
Chief Financial Officer
0$0367,955
(Direct)
View
2022-02-01
Option Award
2022-02-02
4:36 pm
N/A
N/A
Neoleukin Therapeutics Inc.NLTXHo Robert
Chief Financial Officer
70,000$070,000
(Direct)
View
2021-08-03
Option Award
2021-08-05
4:14 pm
N/A
2031-08-03
Neoleukin Therapeutics Inc.NLTXHo Robert
Chief Financial Officer
190,000$0190,000
(Direct)
View
2021-03-16
Exercise
2021-03-18
8:44 pm
N/A
N/A
Neoleukin Therapeutics Inc.NLTXHo Robert
Chief Financial Officer
25,000$071,503
(Direct)
View
2020-08-10
Option Award
2020-08-12
4:10 pm
N/A
2030-08-10
Neoleukin Therapeutics Inc.NLTXHo Robert
Chief Financial Officer
90,000$090,000
(Direct)
View
2020-03-16
Option Award
2020-03-16
9:39 pm
N/A
N/A
Neoleukin Therapeutics Inc.NLTXHo Robert
Chief Financial Officer
275,000$0275,000
(Direct)
View

Ownership
2020-03-16
9:38 pm
N/A
N/A
Neoleukin Therapeutics Inc.NLTXHo Robert
Chief Financial Officer
0$03,000
(Direct)
View